Overview
- 62 inspections across 60 sites are on record.
- 84 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2019-09-16.
At a glance
Inspections
62
Sites
60
Observations
84
Career since
Dec 2014
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| C-Care LLC | 16 Sep 2019 | Human Drugs | View 483 → |
| Medicap Laboratories | 14 Jun 2019 | Human Drugs | On file |
| ANI Pharmaceuticals Canada, Inc. | 7 Jun 2019 | Human Drugs | On file |
| Teva Canada Limited | 31 May 2019 | Human Drugs | On file |
| OLIC (Thailand) Limited | 22 Nov 2018 | Human Drugs |
Sites inspected
C-Care LLCLinthicum Heights, United States1 insp.
Medicap LaboratoriesEtobicoke, Canada1 insp.
ANI Pharmaceuticals Canada, Inc.Oakville, Canada1 insp.
Teva Canada LimitedStouffville, Canada1 insp.
OLIC (Thailand) LimitedBang Pa-In, Thailand1 insp.
Co-investigators
Investigators who share inspections with this person.
Jonathan W Chapman5 shared
Steven P Donald3 shared
Deyaa Shaheen3 shared
Nicole E Knowlton3 shared
Djamila Harouaka2 shared
Nebil A Oumer2 shared
Pratik S Upadhyay2 shared
Toyin B Oladimeji2 shared
Laurissa S Flowers2 shared
Jessica L Pressley2 shared
Full investigator report
Get the verbatim findings behind Qin Xu's 84 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site